We are conducting a healthy volunteer study, here at our facility in Randwick, Sydney.
This study is to test IMSB301, a small molecule drug being developed to provide a new therapeutic treatment for patients with type 1 interferonopathy and other autoimmune disorders, which will be delivered in an oral suspension, likely a syrup.
To be eligible for this study you must:
- Be a generally healthy male or female
- Aged between 18 to 55 years old
- Must have a BMI of between 18.0 and 33.0 kg/m²
- Must have a bodyweight of greater than 45kg for females and greater than 50kg for males
This study requires an in-house stay at our facility of 10 nights / 11 days, with 1 follow-up visit.